- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 211 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- March 2022
- 300 Pages
Global
From €4551EUR$5,000USD£3,901GBP
- Report
- April 2021
- 148 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- April 2021
- 150 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2023
- 120 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 84 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Sucralfate is a medication used to treat and prevent ulcers in the gastrointestinal tract. It works by forming a protective barrier over the ulcer, which helps to reduce irritation and promote healing. It is also used to treat other gastrointestinal conditions such as gastroesophageal reflux disease (GERD) and esophagitis. Sucralfate is available in both oral and topical forms. The oral form is taken as a tablet or suspension, while the topical form is applied directly to the affected area.
Sucralfate is a popular choice for treating and preventing gastrointestinal ulcers due to its effectiveness and low risk of side effects. It is also relatively inexpensive compared to other medications used to treat gastrointestinal conditions.
The sucralfate market is a part of the larger gastrointestinal drugs market. This market includes a variety of medications used to treat and prevent gastrointestinal conditions, such as antacids, proton pump inhibitors, and H2 blockers.
Some companies in the sucralfate market include Pfizer, Merck, and GlaxoSmithKline. These companies produce both generic and branded versions of the medication. Show Less Read more